Cargando…
The cost of multiple sclerosis in Norway
Health economic aspects have been increasingly important during introduction of new treatments for multiple sclerosis. As a partial response for Norway, a cost-of-illness study was carried out to estimate the yearly cost of the illness to society and relate costs and patients’ quality of life to ill...
Autores principales: | Svendsen, B., Myhr, K.-M., Nyland, H., Aarseth, J. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249563/ https://www.ncbi.nlm.nih.gov/pubmed/21080024 http://dx.doi.org/10.1007/s10198-010-0286-7 |
Ejemplares similares
-
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway
por: Grytten, N, et al.
Publicado: (2016) -
Mortality and cause of death in multiple sclerosis in western Norway 1950–2021: a registry-based linkage study
por: Willumsen, Johannes Sverre, et al.
Publicado: (2022) -
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades
por: Grytten, N, et al.
Publicado: (2015) -
Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study
por: Torgauten, Hilde Marie, et al.
Publicado: (2021) -
High incidence and prevalence of MS in Møre and Romsdal County, Norway, 1950–2018
por: Willumsen, Johannes Sverre, et al.
Publicado: (2020)